Skip to playerSkip to main content
  • 5 years ago
Moderna ($MRNA@US) announced on Monday that they plan to expand its COVID-19 vaccine’s trial testing to kids aged 5 to 11. The U.S. drugmaker also said they hope to receive FDA approval as early as the end of the year.

Category

🗞
News